HIF1A and neoplasm: The combination of antiangiogenic agents and HIF-1 inhibitors might be efficacious, as antiangiogenic agents would cut off the tumor’s blood supply, and HIF-1α inhibitors could potentiate the effect of antiangiogenic agents and reduce the potential for the development of drug resistance [46].